Nutritional Intervention in Sarcopenia: Report from the International Conference on Frailty and Sarcopenia Research Task Force

被引:0
|
作者
Landi F. [1 ]
Sieber C. [2 ]
Fielding R.A. [3 ]
Rolland Y. [4 ]
Guralnik J. [5 ]
机构
[1] Fondazione Policlinico A. Gemelli, Catholic University, Rome
[2] Institut für Biomedizin des Alterns, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nürnberg
[3] Nutrition, Exercise Physiology, and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA
[4] Service de Médecine Interne et Gérontologie, Clinique Gérontopôle, Hôpital La Crave, Casselardit, Toulouse
[5] University of Maryland School of Medicine, Baltimore, MD
关键词
clinical trials; nutritional intervention; physical activity; protein supplementation; Sarcopenia;
D O I
10.14283/jfa.2018.26
中图分类号
学科分类号
摘要
Research suggests that poor nutrition is an underlying cause of sarcopenia and frailty, and that dietary interventions may prevent or treat age-related loss of muscle mass and strength. In February 2018, the International Conference on Frailty and Sarcopenia Research Task Force explored the current status of research on nutritional interventions for sarcopenia as well as gaps in knowledge, including whether nutritional supplements must be combined with physical activity, and the role of nutritional intervention in sarcopenic obese individuals. The lack of consistency across trials in terms of target populations, assessments, health-care settings, control groups, and choice of outcomes has made it difficult to draw meaningful conclusions from recent studies. The Task Force recommended large randomized controlled trials in heterogeneous, real-world populations to enable sub-group analysis. The field also needs to reach consensus on what outcomes are most meaningful and what represents clinically meaningful change. © 2018, Serdi and Springer Nature Switzerland AG.
引用
收藏
页码:247 / 252
页数:5
相关论文
共 50 条
  • [1] PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE
    Cesari, M.
    Fielding, R.
    Benichou, O.
    Bernabei, R.
    Bhasin, S.
    Guralnik, J. M.
    Jette, A.
    Landi, F.
    Pahor, M.
    Rodriguez-Manas, L.
    Rolland, Y.
    Roubenoff, R.
    Sinclair, A. J.
    Studenski, S.
    Travison, T.
    Vellas, B.
    JOURNAL OF FRAILTY & AGING, 2015, 4 (03): : 114 - 120
  • [2] Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
    Cesari, M.
    Bernabei, R.
    Vellas, B.
    Fielding, R. A.
    Rooks, D.
    Azzolino, D.
    Mariani, J.
    Oliva, A. A.
    Bhasin, S.
    Rolland, Y.
    JOURNAL OF FRAILTY & AGING, 2022, 11 (02): : 135 - 142
  • [3] SARCOPENIA TRIALS IN SPECIFIC DISEASES: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE
    Vellas, B.
    Fielding, R.
    Bhasin, S.
    Cerreta, F.
    Goodpaster, B.
    Guralnik, J. M.
    Kritchevsky, S.
    Legrand, V.
    Forkin, C.
    Magaziner, J.
    Morley, J. E.
    Rodriguez-Manas, L.
    Roubenoff, R.
    Studenski, S.
    Villareal, D. T.
    Cesari, M.
    JOURNAL OF FRAILTY & AGING, 2016, 5 (04): : 194 - 200
  • [4] Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
    Matteo Cesari
    R. Bernabei
    B. Vellas
    R. A. Fielding
    D. Rooks
    D. Azzolino
    J. Mariani
    A. A. Oliva
    S. Bhasin
    Y. Rolland
    The Journal of Frailty & Aging, 2022, 11 : 135 - 142
  • [5] Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force
    Vellas B.
    Fielding R.A.
    Bens C.
    Bernabei R.
    Cawthon P.M.
    Cederholm T.
    Cruz-Jentoft A.J.
    Del Signore S.
    Donahue S.
    Morley J.
    Pahor M.
    Reginster J.-Y.
    Rodriguez Mañas L.
    Rolland Y.
    Roubenoff R.
    Sinclair A.
    Cesari M.
    The Journal of Frailty & Aging, 2018, 7 (1) : 2 - 9
  • [7] DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH (ICFSR)
    Vellas, B.
    Fielding, R.
    Miller, R.
    Rolland, Y.
    Bhasin, S.
    Magaziner, J.
    Bischoff-Ferrari, H.
    JOURNAL OF FRAILTY & AGING, 2014, 3 (04): : 199 - 204
  • [8] Resilience: Biological Basis and Clinical Significance - A Perspective Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
    Cesari, M.
    Azzolino, D.
    LeBrasseur, N. K.
    Whitson, H.
    Rooks, D.
    Sourdet, S.
    Angioni, D.
    Fielding, R. A.
    Vellas, B.
    Rolland, Y.
    JOURNAL OF FRAILTY & AGING, 2022, 11 (04): : 342 - 347
  • [9] Resilience: Biological Basis and Clinical Significance — A Perspective Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
    Matteo Cesari
    D. Azzolino
    N. K. LeBrasseur
    H. Whitson
    D. Rooks
    S. Sourdet
    D. Angioni
    R. A. Fielding
    B. Vellas
    Y. Rolland
    Sandrine Andrieu
    Mylène Aubertin Leheudre
    Nuria Barcons
    Ann Beliën
    Philipe de Souto Barreto
    Carla Delannoy
    Groarke John
    Luis Miguel Gutierrez Robledo
    Darren Hwee
    Jean Mariani
    Merchant Reshma
    John Morley
    Suzette Pereira
    Quann Erin
    Rossulek Michelle
    Ricardo Rueda
    Lisa Tarasenko
    Cendrine Tourette
    Rob Van Maanen
    Debra L. Waters
    The Journal of Frailty & Aging, 2022, 11 : 342 - 347
  • [10] Combined exercise and nutritional intervention for sarcopenia and frailty
    Sasai, Hiroyuki
    Kim, Hunkyung
    ANNALS OF NUTRITION AND METABOLISM, 2023, 79 : 122 - 123